NW AfriCissus Capsule 400mg
NW AfriCissus Capsule 400mg : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Cissus quadrangularis L. | Cissus quadrangularis L.[250;mg;400;mg] | Not identified |
| IRVINGIA GABONENSIS | IRVINGIA GABONENSIS[150;mg;400;mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL15070041T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Manufacturer
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Registration period starting
- 2025-09-08
- Published validity end
- 2030-09-08
Original register data
View published fields and their variants
- Active ingredients
- Cissus quadrangularis L.[250;mg;400;mg],IRVINGIA GABONENSIS[150;mg;400;mg]
- Valid until
- 2030-09-08
- Registration date
- 2025-09-08
- Published description
- NATURAL PRODUCT
- Licence holder
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Producer
- NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
- Published name
- NW AfriCissus Capsule 400mg
- Published reference
- 2014120903741
- Registration number
- MAL15070041T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL15070041T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- IRVINGIA GABONENSIS
Read the warning, when it applies and the studies cited
AFRICAN WILD MANGO - IRVINGIA GABONENSIS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Ross 2011; Ngondi et al. 2009; Adamson et al. 1986).
Sources cited by Health Canada (3)
- Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme 1986; 36(3): 212-215. PubMed
- Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease 2009; 8:7. PubMed Randomised trial
- Ross MS. A proprietary seed extract of Irvingia gabonensis is found to be effective in reducing body weight and improving metabolic parameters in overweight humans. Holistic Nursery Practice 2011; 235(4): 215-217.
Condition of application: Antioxidant, cholesterol, glucose.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Contraindications
Condition of application: Weight management.
Do not use if you are pregnant.
Known adverse reactions
Stop use if you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache (Adamson et al. 1986; Ngondi et al. 2009; Oben et al. 2008a,b).
Sources cited by Health Canada (3)
- Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme 1986; 36(3): 212-215. PubMed
- Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease 2009; 8:7. PubMed Randomised trial
- Oben JE, Ngondi JL, Blum K. Inhibition of Irvingina gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up- regulation of the adiponectin gene. Lipids in Health and Disease 2008a; 7:44. PubMed
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “NW AfriCissus Capsule 400mg”, https://compoatlas.com/en/supplements/malaysia/MAL15070041T-nw-africissus-capsule-400mg, updated 27 October 2026.